Measurement of the incretin hormones: glucagon-like peptide-1 and glucose-dependent insulinotropic peptide

J Diabetes Complications. 2015 Apr;29(3):445-50. doi: 10.1016/j.jdiacomp.2014.12.006. Epub 2014 Dec 15.

Abstract

The two incretin hormones, glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic peptide (GIP), are secreted from the gastrointestinal tract in response to meals and contribute to the regulation of glucose homeostasis by increasing insulin secretion. Assessment of plasma concentrations of GLP-1 and GIP is often an important endpoint in both clinical and preclinical studies and, therefore, accurate measurement of these hormones is important. Here, we provide an overview of current approaches for the measurement of the incretin hormones, with particular focus on immunological methods.

Keywords: ELISA; Glucagon-like peptide-1; Glucose-dependent insulinotropic peptide; Incretin hormones; RIA.

Publication types

  • Review

MeSH terms

  • Diagnostic Techniques, Endocrine* / standards
  • Gastric Inhibitory Polypeptide / analysis*
  • Gastric Inhibitory Polypeptide / chemistry
  • Gastric Inhibitory Polypeptide / metabolism
  • Glucagon-Like Peptide 1 / analysis*
  • Glucagon-Like Peptide 1 / chemistry
  • Glucagon-Like Peptide 1 / metabolism
  • Humans
  • Immunologic Tests
  • Incretins / analysis*
  • Incretins / chemistry
  • Incretins / metabolism

Substances

  • Incretins
  • Gastric Inhibitory Polypeptide
  • Glucagon-Like Peptide 1